S.Biomedics Co., Ltd. (KOSDAQ:304360)
South Korea
· Delayed Price · Currency is KRW
25,500
+550 (2.20%)
Feb 19, 2025, 9:00 AM KST
S.Biomedics Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Feb '25 Feb 18, 2025 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 287,185 | 130,376 | - | - | - | - | |
| Enterprise Value | 290,771 | 133,226 | - | - | - | - | |
| Last Close Price | 24450.00 | 11500.00 | - | - | - | - | |
| PS Ratio | 21.41 | 9.95 | - | - | - | - | |
| PB Ratio | 27.48 | 10.62 | - | - | - | - | |
| P/TBV Ratio | 38.05 | 19.14 | - | - | - | - | |
| EV/Sales Ratio | 22.33 | 10.16 | - | - | - | - | |
| Debt / Equity Ratio | 0.69 | 0.98 | 13.33 | 1.78 | 1.17 | 0.35 | |
| Asset Turnover | 0.37 | 0.47 | 0.57 | 0.49 | 0.26 | 0.22 | |
| Inventory Turnover | 2.30 | 3.33 | 5.14 | 6.18 | 6.07 | 5.34 | |
| Quick Ratio | 2.23 | 1.65 | 0.75 | 3.19 | 1.96 | 2.97 | |
| Current Ratio | 2.75 | 2.03 | 0.95 | 3.44 | 2.12 | 3.14 | |
| Return on Equity (ROE) | -19.00% | -97.08% | -195.41% | -121.47% | -97.95% | -64.37% | |
| Return on Assets (ROA) | -10.37% | -13.30% | -11.13% | -16.13% | -26.13% | -25.05% | |
| Return on Capital (ROIC) | -13.33% | -19.15% | -18.41% | -27.49% | -38.11% | -31.69% | |
| Earnings Yield | -1.34% | -5.77% | - | - | - | - | |
| FCF Yield | -1.78% | -6.13% | - | - | - | - | |
| Buyback Yield / Dilution | -7.04% | -6.97% | -0.67% | -0.42% | -3.93% | -406.19% | |
| Total Shareholder Return | -7.04% | -6.97% | -0.67% | -0.42% | -3.93% | -406.19% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.